NCT00387946View on ClinicalTrials.gov

Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)

PHASE3CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Smoking CessationTobacco Use Cessation
Interventions
DRUG

SSR591813L (dianicline)

Trial Locations (2)

08807

Administrative Office, Bridgewater

Unknown

Administrative Office, Laval

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00387946 - Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) | Biotech Hunter | Biotech Hunter